Endoscopic AI for Gastric Cancer
Gastric Cancer Detection
Regulatory ReviewApproval Applied (2021)
Key Facts
Indication
Gastric Cancer Detection
Phase
Regulatory Review
Status
Approval Applied (2021)
Company
About AI Medical Service
Japanese AI diagnostics company developing endoscopic systems to detect gastrointestinal cancers and reduce overlooked diagnoses worldwide.
View full company profileTherapeutic Areas
Other Gastric Cancer Detection Drugs
| Drug | Company | Phase |
|---|---|---|
| Aiforia® Gastric Cancer | Aiforia Technologies | CE-IVD Marked |